Equities

Concord Medical Services Holdings Ltd

Concord Medical Services Holdings Ltd

Actions
Health CareHealth Care Providers
  • Price (USD)0.590
  • Today's Change0.079 / 15.49%
  • Shares traded6.10k
  • 1 Year change-56.93%
  • Beta-0.3653
Data delayed at least 15 minutes, as of May 24 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company's segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.

  • Revenue in USD (TTM)74.21m
  • Net income in USD-41.10m
  • Incorporated2007
  • Employees727.00
  • Location
    Concord Medical Services Holdings LtdRoom 26A1-26A5, East Tower, Hanwei, BuilBEIJING 100020ChinaCHN
  • Phone+86 1 058256867
  • Websitehttps://www.concordmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Univec Inc-100.00bn-100.00bn12.87m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Mangoceuticals Inc844.87k-9.02m12.91m--------15.28-0.492-0.4920.0455-0.04060.3826-------408.41---596.95--61.75---1,067.52--0.0622------8,082.22---361.07------
PharmChem Inc6.04m722.90k13.01m170.0019.196.2418.002.150.14590.14591.220.44851.797.6210.04--21.47--25.28--65.12--11.96--3.98------3.50---16.95------
Xcelerate Inc3.96m-296.19k13.36m1.00--9.61--3.38-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Clearday Inc7.54m-21.54m13.66m225.00------1.81-0.9722-0.99380.3147-1.700.3432--201.6333,524.13-77.04-71.37---342.36-----224.52-205.25---0.9413-----3.0594.7325.38---28.32--
Healthlynked Corp4.97m-3.82m14.05m38.00--64.25--2.83-0.0142-0.01430.01850.00080.990713.4033.09130,827.90-76.20-119.37-189.55-332.2255.6655.81-76.92-119.260.6532--0.8047---2.3220.4357.08---12.94--
Psychemedics Corp.21.60m-4.46m15.62m116.00--2.49--0.7232-0.773-0.7733.741.081.49--5.44186,172.40-30.68-7.44-46.72-9.7038.5737.55-20.64-6.26---184.940.0353---12.45-12.33-283.21---33.32--
Pacific Green Technologies Inc89.10m7.88m20.41m45.002.671.242.560.22910.14580.14581.810.31541.99--53.471,979,898.0015.61-12.0348.16-46.7827.5339.687.85-13.35---0.60590.122---50.5230.80-5.25---73.45--
ATI Physical Therapy Inc713.56m-119.67m21.54m6.00k------0.0302-28.91-28.91171.8125.330.7005--7.81118,926.00-5.34---6.12--15.64---7.62-----0.10110.8274--9.97--73.20------
Concord Medical Services Hldgs Ltd (ADR)74.21m-41.10m25.62m727.00------0.3452-0.9409-0.94091.70-6.750.08919.815.27102,079.00-8.81-9.49-85.81-39.24-14.26-15.06-98.81-134.560.2956-5.700.6348--13.8423.0039.21---6.88--
Medirom Healthcare Technologies Inc(ADR)26.21m-3.94m26.93m171.00--20.51--1.03-0.9508-0.95085.890.2690.8847406.6210.40153,263.10-13.29---25.58--17.03---15.03--0.3519-53.290.7856---14.50---3,210.30------
Exagen Inc55.73m-19.36m34.75m174.00--1.73--0.6235-1.09-1.093.131.150.8572--5.52320,304.60-29.78-30.21-34.58-33.7558.7654.86-34.74-55.36---8.070.4998--15.3310.1350.01--33.00--
Nutex Health Inc258.77m-41.00m36.79m800.00--0.5838--0.1422-0.9175-0.91755.711.270.620367.704.41323,463.30-8.88-69.35-10.70-84.8515.4910.97-14.32-102.851.630.24890.7617--12.93428.2289.22------
Data as of May 24 2024. Currency figures normalised to Concord Medical Services Holdings Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.16%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Mar 202440.70k0.15%
RhumbLine Advisers LPas of 31 Mar 20245.46k0.02%
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 202425.000.00%
Aperio Group LLCas of 31 Mar 20240.000.00%
UBS Securities LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.